Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter
Active & Responsive

Bone Marrow and Peripheral Blood Immune Responses Study

for
Influenza
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18 - 64

Code: NCT05616546

Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase 3, Recruiting
Active & Responsive

Systems Investigation of Vaccine Responses in Aging and Frailty

for
Influenza
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21+

Code: NCT05291676

Phase 2, Recruiting
Active & ResponsiveNew

A Study of Updated mRNA Seasonal Influenza Vaccines

for
Seasonal Influenza
Location: Louisville KY, Town and Country MO, Lenexa KS,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 65+

Code: NCT07884175

Phase 4, Recruiting
Active & ResponsiveNew

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children

for
Seasonal Influenza
Location: Richmond VA, South Euclid OH, Minneapolis MN,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 9 - 17

Code: NCT07870330

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
Location: New Haven CT, Lake Success NY, New York NY, Fairfax VA,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07361562

Phase 1, Recruiting
Active & Responsive

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

for
HER2/Neu+ Uterine Serous Carcinoma
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 18 - 70+

Code: NCT02491099

Phase 2, Recruiting
Active & Responsive

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Philadelphia PA, Fairfax VA, Charlotte NC, Nashville TN,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT06043817

Phase 1, Phase 2, Recruiting
Active & Responsive

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

for
HER2-positive Metastatic Breast Cancer
Location: Westerly RI, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06551116

Recruiting
Active & Responsive

MIRA CONNECT Study

for
Pregnancy of Unknown Location (PUL)
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 18 - 40

Code: NCT06802263

Recruiting
Active & Responsive

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

for
Rare Cancers, Cholangiocarcinoma,
Location: Cambridge MA
Sponsor: TargetCancer Foundation

Sex: All

Age: 18+

Code: NCT04504604

Recruiting
Active & Responsive

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

for
Influenza
Location: Miami FL, Smithfield PA, Middleburg Heights OH,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0 - 11

Code: NCT06094010

Phase 3, Recruiting
Active & Responsive

Screening Women With Prior HPV for Anal Neoplasia

for
HPV-related Lower Genital Tract Neoplasias,
Location: New York NY, Charleston SC, Houston TX
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Female

Age: 35+

Code: NCT05217940

Recruiting
Active & Responsive

Study of Screening Brain MRIs in Stage IV Breast Cancer

for
Triple Negative Breast Cancer, HER2-positive Breast Cancer,
Location: Clearwater FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05115474

Phase 2, Recruiting
Active & Responsive

Unidos Contra el VPH

for
Human Papilloma Virus (HPV), Cervical Cancers
Location: El Paso TX
Sponsor: University of Texas at Austin

Sex: Female

Age: 30 - 65

Code: NCT06825689

Recruiting
Active & Responsive

Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections

for
COVID-19 Respiratory Infection, Influenza
Location: Nellis Air Force Base NV
Sponsor: David Moss

Sex: All

Age: 18+

Code: NCT07610967

Recruiting
Active & Responsive

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07659678

Phase 2, Recruiting
Active & Responsive

Comparative Self-collection for Cervical Cancer Screening Pivotal Study

for
HPV, HPV - Anogenital Human Papilloma Virus Infection
Location: Wilmington NC, Raleigh NC, Lake Worth FL,
Sponsor: Mel Mont Medical

Sex: Female

Age: 25 - 65

Code: NCT07758140

Recruiting
Active & Responsive

Asciminib in HER2+ Breast Cancer Brain Metastases

for
HER2+ Metastatic Breast Cancer
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18+

Code: NCT07136428

Phase 1, Phase 2, Recruiting
Active & Responsive

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

for
HPV Infection
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female

Age: 18+

Code: NCT06210854

Phase 2, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial